Parabilis Medicines, Inc. Increase (Decrease) in Deferred Revenue
Parabilis Medicines, Inc. (PBLS) reported Increase (Decrease) in Deferred Revenue of $41.52 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2026-08-13
- 2026-06-30: Increase (Decrease) in Deferred Revenue 6 month $41.52M.
- 2025-06-30: Increase (Decrease) in Deferred Revenue 6 month $0.00.
| Period end | Increase (Decrease) in Deferred Revenue 6 month |
|---|---|
| 2026-06-30 | $41.52M 10-Q · filed 2026-08-13 |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-13 |